Page last updated: 2024-08-23

pravastatin and Adenocarcinoma, Clear Cell

pravastatin has been researched along with Adenocarcinoma, Clear Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, ML; Desai, P; Howard, BV; Manson, JE; Martin, LW; Ray, RM; Rohan, T; Safford, M; Simon, MS; Wallace, R; Wu, C	1

Other Studies

1 other study(ies) available for pravastatin and Adenocarcinoma, Clear Cell

Article	Year
An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative. Gynecologic oncology, 2018, Volume: 148, Issue:3 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aged; Carcinoma, Endometrioid; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Postmenopause; Pravastatin; Proportional Hazards Models; Risk Factors; United States; Women's Health	2018

Article

Year

An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.

Gynecologic oncology, 2018, Volume: 148, Issue:3

Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aged; Carcinoma, Endometrioid; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Postmenopause; Pravastatin; Proportional Hazards Models; Risk Factors; United States; Women's Health

2018